|
1
|
Archambault AN, Su YR, Jeon J, Thomas M,
Lin Y, Conti DV, Win AK, Sakoda LC, Lansdorp-Vogelaar I, Peterse
EFP, et al: Cumulative burden of colorectal cancer-associated
genetic variants is more strongly associated with early-onset vs.
late-onset cancer. Gastroenterology. 158:1274–1286.e12. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sagnelli E, Macera M, Russo A, Coppola N
and Sagnelli C: Epidemiological and etiological variations in
hepatocellular carcinoma. Infection. 48:7–17. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Işçi Bostanci E, Durmuş Y, Duru Çöteli SA,
Kayikçioğlu F and Boran N: Outcomes of the conservative management
of the patients with endometrial intraepithelial
neoplasia/endometrial cancer: Wait or treat! Turk J Med Sci. May
20–2021.(Epub ahead of print).
|
|
4
|
Heyn GS, Corrêa LH and Magalhães KG: The
impact of adipose tissue-derived miRNAs in metabolic syndrome,
obesity, and cancer. Front Endocrinol (Lausanne). 11:5638162020.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marino N, German R, Rao X, Simpson E, Liu
S, Wan J, Liu Y, Sandusky G, Jacobsen M, Stoval M, et al:
Upregulation of lipid metabolism genes in the breast prior to
cancer diagnosis. NPJ Breast Cancer. 6:502020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Philp LK, Rockstroh A, Lehman M, Sadowski
MC, Bartonicek N, Wade JD, Otvos L and Nelson CC: Adiponectin
receptor activation inhibits prostate cancer xenograft growth.
Endocr Relat Cancer. 27:711–729. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Llanos AAM, Yao S, Singh A, Aremu JB,
Khiabanian H, Lin Y, Omene C, Omilian AR, Khoury T, Hong CC, et al:
Gene expression of adipokines and adipokine receptors in the tumor
microenvironment: Associations of lower expression with more
aggressive breast tumor features. Breast Cancer Res Treat.
185:785–798. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu X, Long X, Yang C, Chen H, Sharkey C,
Rashid K, Hu M, Liu Y, Huang Q, Chen Q, et al: Icaritin reduces
prostate cancer progression via inhibiting high-fat diet-induced
serum adipokine in TRAMP mice model. J Cancer. 11:6556–6564. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wong GW, Krawczyk SA, Kitidis-Mitrokostas
C, Revett T, Gimeno R and Lodish HF: Molecular, biochemical and
functional characterizations of C1q/TNF family members:
Adipose-tissue-selective expression patterns, regulation by
PPAR-gamma agonist, cysteine-mediated oligomerizations,
combinatorial associations and metabolic functions. Biochem J.
416:161–177. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sarver DC, Stewart AN, Rodriguez S, Little
HC, Aja S and Wong GW: Loss of CTRP4 alters adiposity and food
intake behaviors in obese mice. Am J Physiol Endocrinol Metab.
319:E1084–E1100. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shanaki M, Shabani P, Goudarzi A, Omidifar
A, Bashash D and Emamgholipour S: The C1q/TNF-related proteins
(CTRPs) in pathogenesis of obesity-related metabolic disorders:
Focus on type 2 diabetes and cardiovascular diseases. Life Sci.
256:1179132020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rasooli Tehrani A, Gholipour S, Sharifi R,
Yadegari S, Abbasi-Kolli M and Masoudian N: Plasma levels of
CTRP-3, CTRP-9 and apelin in women with multiple sclerosis. J
Neuroimmunol. 333:5769682019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kishore U, Gaboriaud C, Waters P, Shrive
AK, Greenhough TJ, Reid KB, Sim RB and Arlaud GJ: C1q and tumor
necrosis factor superfamily: Modularity and versatility. Trends
Immunol. 25:551–561. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schäffler A and Buechler C: CTRP family:
Linking immunity to metabolism. Trends Endocrinol Metab.
23:194–204. 2012. View Article : Google Scholar
|
|
15
|
Wong GW, Wang J, Hug C, Tsao TS and Lodish
HF: A family of Acrp30/adiponectin structural and functional
paralogs. Proc Natl Acad Sci USA. 101:10302–10307. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tan SY, Little HC, Sarver DC, Watkins PA
and Wong GW: CTRP12 inhibits triglyceride synthesis and export in
hepatocytes by suppressing HNF-4α and DGAT2 expression. FEBS Lett.
594:3227–3239. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lei X and Wong GW: C1q/TNF-related protein
2 (CTRP2) deletion promotes adipose tissue lipolysis and hepatic
triglyceride secretion. J Biol Chem. 294:15638–15649. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moradi N, Najafi M, Sharma T, Fallah S,
Koushki M, Peterson JM, Meyre D and Fadaei R: Circulating levels of
CTRP3 in patients with type 2 diabetes mellitus compared to
controls: A systematic review and meta-analysis. Diabetes Res Clin
Pract. 169:1084532020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qian M, Yang Q, Li J, Zhao B, Zhang Y and
Zhao Y: C1q/TNF-related protein-9 alleviates airway inflammation in
asthma. Int Immunopharmacol. 81:1062382020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peterson JM, Wei Z and Wong GW: CTRP8 and
CTRP9B are novel proteins that hetero-oligomerize with C1q/TNF
family members. Biochem Biophys Res Commun. 388:360–365. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schäffler A, Ehling A, Neumann E, Herfarth
H, Paul G, Tarner I, Gay S, Schölmerich J and Müller-Ladner U:
Genomic organization, promoter, amino acid sequence, chromosomal
localization, and expression of the human gene for CORS-26
(collagenous repeat-containing sequence of 26-kDa protein). Biochim
Biophys Acta. 1630:123–129. 2003. View Article : Google Scholar
|
|
22
|
Maeda T, Abe M, Kurisu K, Jikko A and
Furukawa S: Molecular cloning and characterization of a novel gene,
CORS26, encoding a putative secretory protein and its possible
involvement in skeletal development. J Biol Chem. 276:3628–3634.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Byerly MS, Petersen PS, Ramamurthy S,
Seldin MM, Lei X, Provost E, Wei Z, Ronnett GV and Wong GW:
C1q/TNF-related protein 4 (CTRP4) is a unique secreted protein with
two tandem C1q domains that functions in the hypothalamus to
modulate food intake and body weight. J Biol Chem. 289:4055–4069.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Q, Wu J, Xi W, Chen X, Wang W, Zhang T,
Yang A and Wang T: Ctrp4, a new adipokine, promotes the
differentiation of osteoblasts. Biochem Biophys Res Commun.
512:224–229. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kirketerp-Møller N, Bayarri-Olmos R,
Krogfelt KA and Garred P: C1q/TNF-related protein 6 is a pattern
recognition molecule that recruits collectin-11 from the complement
system to ligands. J Immunol. 204:1598–1606. 2020. View Article : Google Scholar
|
|
26
|
Lei X, Seldin MM, Little HC, Choy N,
Klonisch T and Wong GW: C1q/TNF-related protein 6 (CTRP6) links
obesity to adipose tissue inflammation and insulin resistance. J
Biol Chem. 292:14836–14850. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Akiyama H, Furukawa S, Wakisaka S and
Maeda T: CTRP3/cartducin promotes proliferation and migration of
endothelial cells. Mol Cell Biochem. 304:243–248. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao G, Zhang L, Qian D, Sun Y and Liu W:
miR-495-3p inhibits the cell proliferation, invasion and migration
of osteosarcoma by targeting C1q/TNF-related protein 3. Onco
Targets Ther. 12:6133–6143. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Glogowska A, Thanasupawat T, Beiko J, Pitz
M, Hombach-Klonisch S and Klonisch T: Novel CTRP8-RXFP1-JAK3-STAT3
axis promotes Cdc42-dependent actin remodeling for enhanced
filopodia formation and motility in human glioblastoma cells. Mol
Oncol. May 7–2021.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Akiyama H, Furukawa S, Wakisaka S and
Maeda T and Maeda T: Elevated expression of CTRP3/cartducin
contributes to promotion of osteosarcoma cell proliferation. Oncol
Rep. 21:1477–1481. 2009.PubMed/NCBI
|
|
31
|
Akiyama H, Furukawa S, Wakisaka S and
Maeda T: Cartducin stimulates mesenchymal chondroprogenitor cell
proliferation through both extracellular signal-regulated kinase
and phosphatidylinositol 3-kinase/Akt pathways. FEBS J.
273:2257–2263. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li JM, Zhang X, Nelson PR, Odgren PR,
Nelson JD, Vasiliu C, Park J, Morris M, Lian J, Cutler BS and
Newburger PE: Temporal evolution of gene expression in rat carotid
artery following balloon angioplasty. J Cell Biochem. 101:399–410.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hill CS and Treisman R: Transcriptional
regulation by extracellular signals: Mechanisms and specificity.
Cell. 80:199–211. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Seger R and Krebs EG: The MAPK signaling
cascade. FASEB J. 9:726–735. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Coltella N, Manara MC, Cerisano V,
Trusolino L, Di Renzo MF, Scotlandi K and Ferracini R: Role of the
MET/HGF receptor in proliferation and invasive behavior of
osteosarcoma. FASEB J. 17:1162–1164. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bentov I, LeRoith D and Werner H: The WT1
Wilms' tumor suppressor gene: A novel target for insulin-like
growth factor-I action. Endocrinology. 144:4276–4279. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim JY, Min JY, Baek JM, Ahn SJ, Jun HY,
Yoon KH, Choi MK, Lee MS and Oh J: CTRP3 acts as a negative
regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling
in vitro and RANKL-induced calvarial bone destruction in vivo.
Bone. 79:242–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fattovich G, Stroffolini T, Zagni I and
Donato F: Hepatocellular carcinoma in cirrhosis: Incidence and risk
factors. Gastroenterology. 127 (5 Suppl 1):S35–S50. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jung YY, Um JY, Nasif O, Alharbi SA, Sethi
G and Ahn KS: Blockage of the JAK/STAT3 signaling pathway in
multiple myeloma by leelamine. Phytomedicine. Apr 15–2021.(Epub
ahead of print). View Article : Google Scholar
|
|
40
|
Hang T, Yang L, Zhang X, Li J, Long F, Zhu
N, Li Y, Xia J, Zhang Y, Zhang P, et al: Peroxisome
proliferator-activated receptor γ improves pemetrexed therapeutic
efficacy in non-squamous non-small cell lung cancer. Am J Transl
Res. 13:2296–2307. 2021.PubMed/NCBI
|
|
41
|
Li Q, Wang L, Tan W, Peng Z, Luo Y, Zhang
Y, Zhang G, Na D, Jin P, Shi T, et al: Identification of
C1qTNF-related protein 4 as a potential cytokine that stimulates
the STAT3 and NF-κB pathways and promotes cell survival in human
cancer cells. Cancer Lett. 308:203–214. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Grivennikov S, Karin E, Terzic J, Mucida
D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H,
Eckmann L and Karin M: IL-6 and Stat3 are required for survival of
intestinal epithelial cells and development of colitis-associated
cancer. Cancer Cell. 15:103–113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xia Y, Shen S and Verma IM: NF-kappaB, an
active player in human cancers. Cancer Immunol Res. 2:823–830.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang R, Shao X, Yang J, Liu Z, Chew L and
Shao Y: Ginkgo biloba extract mechanism inhibits
hepatocellular carcinoma through the nuclear factor-κB/p53
signaling pathway. J Environ Pathol Toxicol Oncol. 39:179–189.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yang YM, Kim SY and Seki E: Inflammation
and liver cancer: Molecular mechanisms and therapeutic targets.
Semin Liver Dis. 39:26–42. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Naugler WE, Sakurai T, Kim S, Maeda S, Kim
K, Elsharkawy AM and Karin M: Gender disparity in liver cancer due
to sex differences in MyD88-dependent IL-6 production. Science.
317:121–124. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li Y, Ye L, Jia G, Chen H, Yu L and Wu D:
C1q/TNF-related protein 4 induces signal transducer and activator
of transcription 3 pathway and modulates food intake. Neuroscience.
429:1–9. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yu H, Lee H, Herrmann A, Buettner R and
Jove R: Revisiting STAT3 signalling in cancer: New and unexpected
biological functions. Nat Rev Cancer. 14:736–746. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Balkwill F: TNF-alpha in promotion and
progression of cancer. Cancer Metastasis Rev. 25:409–416. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kim MJ, Lee W, Park EJ and Park SY:
C1qTNF-related protein-6 increases the expression of interleukin-10
in macrophages. Mol Cells. 30:59–64. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang L, Liu Z, Duan L, Ma B and Sun Z: C1q
tumor necrosis factor-related protein 6 (CTRP6) inhibits the
proliferation and migration of ovarian cancer cells. Xi Bao Yu Fen
Zi Mian Yi Xue Za Zhi. 31:1664–1668. 2015.(In Chinese). PubMed/NCBI
|
|
52
|
Wan X, Zheng C and Dong L: Inhibition of
CTRP6 prevented survival and migration in hepatocellular carcinoma
through inactivating the AKT signaling pathway. J Cell Biochem.
120:17059–17066. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Takeuchi T, Adachi Y and Nagayama T:
Expression of a secretory protein CTRP6, a C1qTNF family member, in
hepatocellular carcinoma. Anal Cell Pathol (Amst). 34:113–121.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lin W, Chen X, Chen T, Liu J, Ye Y, Chen
L, Qiu X, Chia-Hsien Cheng J, Zhang L, Wu J and Qiu S: C1QTNF6 as a
novel diagnostic and prognostic biomarker for clear cell renal cell
carcinoma. DNA Cell Biol. 39:1000–1011. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Milone M, Desiderio A, Velotti N,
Manigrasso M, Vertaldi S, Bracale U, D'Ambra M, Servillo G, De
Simone G, De Palma FDE, et al: Surgical stress and metabolic
response after totally laparoscopic right colectomy. Sci Rep.
11:96522021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
James S, Aparna JS, Babu A, Paul AM,
Lankadasari MB, Athira SR, Kumar SS, Vijayan Y, Namitha NN,
Mohammed S, et al: Cardamonin attenuates experimental colitis and
associated colorectal cancer. Biomolecules. 11:6612021. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Gou JX, Jiang XJ, Qu HX and Cui YX:
Expression of Complement C1q/Tumor Necrosis Factor Related Protein
6 in Colon Cancer. J Gastroenterol Hepatol. 28:313–316. 2019.
|
|
58
|
Lei H, Wu D, Wang JY, Li L, Zhang CL, Feng
H, Fu FY and Wu LL: C1q/tumor necrosis factor-related protein-6
attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A
pathway and inhibiting myofibroblast differentiation. Basic Res
Cardiol. 110:352015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Xu E, Yin C, Yi X and Liu Y: Knockdown of
CTRP6 inhibits high glucose-induced oxidative stress, inflammation
and extracellular matrix accumulation in mesangial cells through
regulating the Akt/NF-κB pathway. Clin Exp Pharmacol Physiol.
47:1203–1211. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang YP, Zhao YJ and Kong XL: A
metalloproteinase of the disintegrin and metalloproteinases and the
ThromboSpondin Motifs 6 as a novel marker for colon cancer:
Functional experiments. Genet Mol Biol. 43:e201902662020.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Cao L, Tan W, Chen W, Huang H, He M, Li Q,
Zhu X and Wang L: CTRP4 acts as an anti-inflammatory factor in
macrophages and protects against endotoxic shock. Eur J Immunol.
51:380–392. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Gillen CD, Walmsley RS, Prior P, Andrews
HA and Allan RN: Ulcerative colitis and Crohn's disease: A
comparison of the colorectal cancer risk in extensive colitis. Gut.
35:1590–1592. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lv W, Li Q, Jia B, He Y, Ru Y, Guo Q, Li X
and Lin W: Differentiated embryonic chondrocyte-expressed gene 1
promotes temozolomide resistance by modulating the SP1-MGMT axis in
glioblastoma. Am J Transl Res. 13:2331–2349. 2021.PubMed/NCBI
|
|
64
|
Thanasupawat T, Glogowska A, Burg M, Wong
GW, Hoang-Vu C, Hombach-Klonisch S and Klonisch T: RXFP1 is
targeted by complement C1q tumor necrosis factor-related factor 8
in brain cancer. Front Endocrinol (Lausanne). 6:1272015. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Guo X, Liu Y, Huang X, Wang Y, Qu J and Lv
Y: Serum relaxin as a diagnostic and prognostic marker in patients
with epithelial ovarian cancer. Cancer Biomark. 21:81–87. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Klonisch T, Bialek J, Radestock Y,
Hoang-Vu C and Hombach-Klonisch S: Relaxin-like ligand-receptor
systems are autocrine/paracrine effectors in tumor cells and
modulate cancer progression and tissue invasiveness. Adv Exp Med
Biol. 612:104–118. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Silvertown JD, Symes JC, Neschadim A,
Nonaka T, Kao JC, Summerlee AJ and Medin JA: Analog of H2 relaxin
exhibits antagonistic properties and impairs prostate tumor growth.
FASEB J. 21:754–65. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Klonisch T, Glogowska A, Thanasupawat T,
Burg M, Krcek J, Pitz M, Jaggupilli A, Chelikani P, Wong GW and
Hombach-Klonisch S: Structural commonality of C1q TNF-related
proteins and their potential to activate relaxin/insulin-like
family peptide receptor 1 signalling pathways in cancer cells. Br J
Pharmacol. 174:1025–1033. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Thanasupawat T, Glogowska A, Burg M, Krcek
J, Beiko J, Pitz M, Zhang GJ, Hombach-Klonisch S and Klonisch T:
C1q/TNF-related peptide 8 (CTRP8) promotes temozolomide resistance
in human glioblastoma. Mol Oncol. 12:1464–1479. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Chen L and Su G: Identification of CTRP1
as a prognostic biomarker and oncogene in human glioblastoma.
Biomed Res Int. 2019:25824162019.PubMed/NCBI
|
|
71
|
Maeda T, Jikko A, Abe M, Yokohama-Tamaki
T, Akiyama H, Furukawa S, Takigawa M and Wakisaka S: Cartducin, a
paralog of Acrp30/adiponectin, is induced during chondrogenic
differentiation and promotes proliferation of chondrogenic
precursors and chondrocytes. J Cell Physiol. 206:537–544. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Qu HX, Cui L, Meng XY, Wang ZJ, Cui YX, Yu
YP, Wang D and Jiang XJ: C1QTNF6 is overexpressed in gastric
carcinoma and contributes to the proliferation and migration of
gastric carcinoma cells. Int J Mol Med. 43:621–629. 2019.PubMed/NCBI
|
|
73
|
Wang C, Gao C, Zhuang JL, Ding C and Wang
Y: A combined approach identifies three mRNAs that are
down-regulated by micro RNA-29b and promote invasion ability in the
breast cancer cell line MCF-7. J Cancer Res Clin Oncol.
138:2127–2136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Zhang W and Feng G: C1QTNF6 regulates cell
proliferation and apoptosis of NSCLC in vitro and in vivo. Biosci
Rep. 41:BSR202015412021. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Han M, Wang B, Zhu M and Zhang Y: C1QTNF6
as a novel biomarker regulates cellular behaviors in A549 cells and
exacerbates the outcome of lung adenocarcinoma patients. In Vitro
Cell Dev Biol Anim. 55:614–621. 2019. View Article : Google Scholar : PubMed/NCBI
|
